Skip to main content
SpringerLink
Log in

Technique and results of regional hyperthermic cytostatic arm perfusion for malignant melanoma

  • Original Articles
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Isolated hyperthermic cytostatic limb perfusion has been established as an efficient procedure for the treatment of malignant melanoma of the limbs. However, perfusions of the upper extremities are generally carried out much less frequently than would be expected given the distribution pattern of malignant melanoma and sarcoma. Thus, isolated descriptions of treatment results for perfusion of the upper extremities are not available. Between 1991 and 1994, arm perfusions using melphalan 1.0mg/kg body weight were given to 14 patients with malignant melanoma, using the standardized method of perfusion described herein. Within an average observation period of 34.9 months (range, 12–65 months), 11 (78.7%) of the 14 patients who had M.D. Anderson stage II–IV melanoma remained free of local recurrence. In fact, 10 (71.6%) of the patients were still alive at the end of the observation period. None of the 14 patients showed any systemic adverse effects, although 1 patient developed a lymphedema 32 months after perfusion and 2 patients showed a postoperative temporary neurologic deficit. These results demonstrate that isolated perfusion of the upper limb with heat and melphalan under standardized conditions remains the treatment of choice for melanoma of the arm, as for melanoma of the leg, without a higher rate of complications.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Eichfeld U, Gläser A, Schneider G, Kraus J, Pauer HJ, Schwarz I (1993) Die regionale zytostatische Extremitätenperfusion bei Patienten mit malignem Melanom und Weichteilsarkom —therapeutische Anwen-dungen und Ergebnisse. Zentralbl Chir 118:63–68

    CAS  PubMed  Google Scholar 

  2. Hohenberger W, Meyer T, Göhl J (1994) Extremitätenperfusion beim malignen Melanom. Chirurg 65:175–185

    CAS  PubMed  Google Scholar 

  3. Kettelhach C, Kraus T, Hupp T, Manner M, Schlag P (1990) Hyperthermic limb perfusion for malignant melanoma and soft tissue sarcoma. Eur J Surg Oncol 16:370–375

    Google Scholar 

  4. Hafstrom L, Rudenstam CM, Blomquist E, Ingvar C, Jonsson PE, Lagerlof B, Lindholm C, Ringborg U, Westman G, Ostrup L (1991) Regional hyperthermic perfusion with melphalan after surgery for recurrent malignant melanoma of the extremities. Swedish Melanoma Study Group. J Clin Oncol 9:2091–2094

    CAS  PubMed  Google Scholar 

  5. Ghussen F, Krüger I, Groth W, Stützer H (1988) The role of regional hyperthermic cytostatic perfusion in the treatment of extremity melanoma. Cancer 61:654–659

    CAS  PubMed  Google Scholar 

  6. Krementz ET, Carter RD, Sutherland CM, Campbell M (1979) The use of regional chemotherapy in the management of malignant melanoma. World J Surg 3:289–294

    Article  CAS  PubMed  Google Scholar 

  7. Krementz ET, Ryan RF, Muchmore JH, Carter RD (1992) Hyperthermic regional perfusion for melanoma of the limbs. In: Balch CM, Houghton AN, Milton GW, Soober AJ, Soong SJ (eds) Cutaneous melanoma. Lippincott, Philadelphia, pp 403–421

    Google Scholar 

  8. Creech O Jr, Kremenz ET, Ryan RF, Winblad JN (1958) Chemotherapy of cancer: regional perfusion utilizing an extracorporal circuit. Ann Surg 148:616–632

    PubMed  Google Scholar 

  9. Cavalière R, Ciogatto EC, Giovanella BC, Heidelberger C, Johnson RO, Margottini M, Mondovi B, Moricca G, Rossi-Fanelli A (1967) Selective heat sensitivity of cancer cells: Biochemical and clinical studies. Cancer 20:1351–1381

    PubMed  Google Scholar 

  10. Oleson JR, Calderwood SK, Couglin CT, Dewhirst MW, Gerweck LE, Gibbs FA, Kapp DS (1988) Biological and clinical aspects of hyperthermia in cancer therapy. Am J Clin Oncol 11:368–380

    CAS  PubMed  Google Scholar 

  11. Pace M, Filomena A, Galli A (1991) Thermal induction and temperature control in the hyperthermic antiblastic regional perfusion with extracorporeal circulation. Adv Exp Med Biol 267:399–406

    Google Scholar 

  12. Strom R, Crifo C, Rossi-Fanelli A (1977) Biochemical aspects of heat sensivity of tumour cells. In: Selective heat sensitivity of cancer cells. Recent Results Cancer Res 59:229–241

  13. Stehlin JS, Giovanella BC, de Ipolyi PD, Muenz LR, Anderson RF (1975) Results of hyperthermic perfusion for melanoma of the extremities. Surg Gynecol Obstet 140:339–348

    CAS  PubMed  Google Scholar 

  14. Lienard D, Ewalenko P, Delmotte JJ, Renard N, Lejeune FJ (1992) High-dose recombinant tumor necrosis factor alpha in combination with interferon gamma and melphalan in isolation perfusion of the limbs for melanoma and sarcoma. J Clin Oncol 10:52–58

    CAS  PubMed  Google Scholar 

  15. Sigurdsson GH, Nachbur B, Lejeune FJ (1993) Anesthesiologist's management of isolated limb perfusion with “high-dose” tumor necrosis factor alpha. Anesthesiology 79:1433–1437

    CAS  PubMed  Google Scholar 

  16. Lienard D, Lejeune FJ, Ewalenko P (1992) In transit metastases of malignant melanoma treated by high dosr rTNF alpha in combination with interferon gamma and melphalan in isolation perfusion. World J Surg 16:234–240

    CAS  PubMed  Google Scholar 

  17. Vaglini M, Belli F, Ammatuna M, Inglese MG, Manzi R, Prada A, Persiani L, Santinami M, Santoro N, Cascinelli N (1994) Treatment of primary or relapsing limb cancer by isolation perfusion with high-dose alpha-tumor necrosis factor, gamma interferon, and melphalan. Cancer 73:483–492

    CAS  PubMed  Google Scholar 

  18. Kroon BBR (1988) Regional isolation perfusion in melanoma of the limbs; accomplishments, unsolved problems, future. Eur J Surg Oncol 14:101–106

    CAS  PubMed  Google Scholar 

  19. Rauschecker HF, Foth H, Michaelis HC, Horst F, Gatzemeier W, Willenbrock D, Voth E, Kahl GF (1991) Kinetics of melphalan leakage during hyperthermic isolation perfusion in melanoma of the limb. Cancer Chemother Pharmacol 27:379–384

    Article  CAS  PubMed  Google Scholar 

  20. Thompson JF, Gianoutsos MP (1992) Isolated limbs perfusion for melanoma: effectiveness and toxicity of cisplatin compared with that of melphalan and other drugs. World J Surg 16:227–233

    CAS  PubMed  Google Scholar 

  21. Hoeckstra HJ, Schraffordt Koops H, de Vries LGE, van Weerden TW, Oldhoff J (1993) Toxicity of hyperthermic isolated limb perfusion with cisplatin for recurrent melanoma of the lower extremity after previous perfusion treatment. Cancer 72:1224–1229

    Google Scholar 

  22. Lejeune FJ, Lienard D, El Douahy M, Seyedi JV, Ewalenko P (1989) Results of 206 isolated limb perfusions for malignant melanoma. Eur J Surg Oncol 15:510–519

    CAS  PubMed  Google Scholar 

  23. Hohenberger W (1990) Isolation perfusion for malignant melanomas: established facts and parameters to be clarrified. In: Jakesz R, Rainer H (eds) Progress in regional cancer therapy. Springer, Berlin Heidelberg New York, pp 182–197

    Google Scholar 

  24. Krementz ET (1987) Regional perfusion for melanoma of the limbs: prospects for cooperative studies in North America. In: Veronesi U, Cascinelli N, Santinami M (eds) Cutaneous melanoma. Status of knowledge and future perspetive. Academic, London, pp 589–611

    Google Scholar 

  25. Schraffordt Koops H, Kroon BB, Oldhoff J, Hoekstra HJ (1992) Controversies concerning adjuvant regional isolated perfusion for stage I melanoma of extremities. World J Surg; 16:241–245

    CAS  PubMed  Google Scholar 

  26. Mastrangelo MJ, Baker AR, Katz HR (1985) Cutaneous melanoma. In: De Vita VT, Hellmann S, Rosenberg SA (eds) Cancer: principles and practice of oncology. Lippincott, Philadelphia, pp 1124–1170

    Google Scholar 

  27. Chang AE, Rees RS (1993) Cutaneous neoplasms. In: Greenfield LJ, Mulholland MW, Oldham KT, Zelenock GB (eds) Surgery: scientific principles and practice. Lippincott, Philadelphia, pp 2019–2035

    Google Scholar 

  28. Hölzle E, Kind P, Plewig G (1991) Pigmentierte Hautverän derungen: Klinik — Histopathologie — Differentialdiagnosen. Schattauer, Stuttgart, pp 1–128

    Google Scholar 

  29. Cumberlin R, de Moss E, Lassus M, Friedman M (1985) Isolation perfusion for malignant melanoma of the extremity: a review. J Clin Oncol 3:1022–1032

    CAS  PubMed  Google Scholar 

  30. Ghussen F, Krüger I, Groth W, Stützer H (1986) Randomisierte Melanomstudie zur Extremitätenperfusion. Behandlungsergebnisse 2 1/2 Jahre nach vorzeitigem Abbruch. Chirurg 57:619–624

    CAS  PubMed  Google Scholar 

  31. Janoff KA, Moseson D, Nohlgren J, Davenport C, Richards C, Fletcher WS (1982) The treatment of stage I melanoma of the extremities with regional hyperthermic isolation perfusion. Ann Surg 196:316–323

    CAS  PubMed  Google Scholar 

  32. Krementz ET (1986) Regional perfusion. Current sophistication, what next? Cancer 57:416–419

    CAS  PubMed  Google Scholar 

  33. Martijn H, Oldhoff J, Schraffordt Koops H (1981) Regional perfusion in the treatment of patients with a locally metastasized malignant melanoma of the limbs. Europ J Cancer 17:471–479

    CAS  Google Scholar 

  34. Nagel K, Junginger T (1987) Extremitätenperfusion beim malignen Melanom. DMW 112:1626–1629

    CAS  Google Scholar 

  35. Veronesi U, Adamus J, Bandiera DC, Brennhovd O, Caceres E, Cascinelli N, Claudio F, Ikonopisov RL, Javorski VV, Kirov S, Kulakowski A, Lacour J, Lejeune F, Mechl Z, Morabito A, Rodé I, Sergeev S, van Slooten E, Szczygiel K, Trapeznikov NN, Wagner RI (1982) Delayed regional lymph node dissection in stage I melanoma of the skin of the lower extremities. Cancer 49:2420–2430

    CAS  PubMed  Google Scholar 

  36. Manner M, Sinn H, Bubeck H, Kettelhack C, Schlag P (1990) Verbesserte intraoperative Leckkontrolle bei der isolierten Zytostatikaperfusion von Extremitätentumoren. Langenbecks Arch 375:208–213

    CAS  Google Scholar 

  37. Krauss J, Lange U, Pauer HD, Krauss I (1984) Farbstoffkonzentrationsmessungen zur Abstrombestimmung während und nach der zytostatischen Perfusion zur Behandlung von Extremitätentumoren. Z Exp Chir Transplant Künstl Organe 17:269–274

    CAS  Google Scholar 

  38. Klaase JM, Kroon BB, van Geel AN, Eggermont AM, Franklin HR, Hart AA (1994) Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan. Surgery 115:39–45

    CAS  PubMed  Google Scholar 

  39. Bryant PJ, Balderson GA, Mead P, Egerton WS (1995) Hyperthermic isolated limb perfusion for malignant melanoma: response and survival. World J Surg 19:363–368

    Article  CAS  PubMed  Google Scholar 

  40. Clark WH Jr, From L, Bernardino EA, Mihm MC (1969) The histogenesis and biologic behavior of primary malignant melanomas of the skin. Cancer Res 29:705–711

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of General Surgery, Martin-Luther-University Halle, Ernst-Grube-Straße 40, 06120, Halle, Germany

    Peter Würl, Uwe Eichfeld, Hans-Dieter Pauer, Albrecht Gläser, Uwe Rose & Henning Dralle

Authors
  1. Peter Würl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Uwe Eichfeld
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Hans-Dieter Pauer
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Albrecht Gläser
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Uwe Rose
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Henning Dralle
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Würl, P., Eichfeld, U., Pauer, HD. et al. Technique and results of regional hyperthermic cytostatic arm perfusion for malignant melanoma. Surg Today 27, 719–725 (1997). https://doi.org/10.1007/BF02384984

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02384984

Key Words

Search

Navigation